XBI (Biotech) Stock Analysis - Insider Trades

Biotech (XBI) is a publicly traded the market company. As of May 20, 2026, XBI trades at $131.56 with a market cap of $0 and a P/E ratio of 0.00. XBI moved +3.92% today. Year to date, XBI is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces XBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XBI stock inside the company?

Rallies tracks XBI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

XBI Key Metrics

Key financial metrics for XBI
MetricValue
Price$131.56
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume10.38M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XBI News

XBI Analyst Consensus

XBI analyst coverage data. Average price target: $0.00.

Common questions about XBI

Who is trading XBI stock inside the company?
Rallies tracks XBI insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for XBI?
Yes. Rallies tracks XBI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XBI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XBI. It does not provide personalized investment advice.
XBI

Biotech